Back to Authors

Sadighi Akha, Amir A

0000-0001-8947-9967

Mayo Clinic

Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, USA.

Citations 2

Cellular Viability of Whole Blood Specimens Is a Sensitive Indicator of Transport Conditions
Ennis, Scott M, Yang, Yifei , Akha, Amir A. Sadighi, Kumánovics, Attila, Sadighi Akha, Amir A , Kumánovics, Attila

Archives of Pathology & Laboratory Medicine | August 8, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.5858/arpa.2026-0046-oa Get It

Context.— Transporting specimens can expose them to uncontrolled environmental factors. Whole blood viability is a commonly used preanalytic marker of quality for analysis of white blood cells. Objective.— To evaluate whole blood viability as a marker for transportation and specimen integrity for lymphocyte subset evaluation. Design.— More than 9000 whole blood specimens, transported during a 4-year period, and their lymphocyte subset evaluation results were analyzed retrospectively. Viability was measured by using Cellaca MX imaging cytometer, and lymphocyte and lymphocyte subset counts were determined with flow cytometry. Specimen cell viability results were stratified based on different transportation factors to discern their potential effects. Lymphocyte subset evaluation results from specimens with lower viability were compared with those from optimal viability specimens. Results.— Cell viability of transported specimens exhibited seasonal variation, decreasing during the warm summer months (median, 77.0% versus 83.4% in other seasons). The decline in viability negatively correlated with ambient temperature during transportation ( r = −0.7876). Longer transportation time (>60 hours) also caused a decrease in viability (median, 64.0%). While we observed a decrease in absolute cell counts for CD45 + lymphocytes, CD3 + T cells, CD8 + T cells, and CD19 + B cells in specimens with low viability (50%–80%), the differences were well within the assay’s total allowable error. Conclusions.— Control of preanalytic factors is critical for laboratory testing. Whole blood viability is a sensitive indicator of transport conditions and time, but it is not a specific predictor of quality for the main lymphocyte populations in cellular immunology testing.
Hematopoietic stem cell transplant with a carrier donor rescues CD40L deficiency
Ebens, Christen L. , Vasanna, Smitha Hosahalli, Vilkama, Diana , Pozos, Tamara C. , Kumánovics, Attila , Hornyak, Alison , Akha, Amir A. Sadighi, Hosahalli Vasanna, Smitha , Sadighi Akha, Amir A , Ebens, Christen L

Journal of Human Immunity | February 5, 2026 | Volume: 2 | Issue: 3 | Pages: No page available

10.70962/jhi.20250212 Get It

This study demonstrates successful hematopoietic stem cell transplant of CD40L deficiency using an asymptomatic carrier mother, leading to sustained 32% CD40L expression, normal recovery of T and B cell development and diversity, and expected growth and development 7.5 years post-transplant.